Cambridge, MA, United States of America

Birte Nolting

USPTO Granted Patents = 2 

Average Co-Inventor Count = 2.4

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Birte Nolting: Innovator in Lipid Nanoparticle Technology

Introduction

Birte Nolting is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of lipid nanoparticle technology, focusing on innovative compositions and their applications in drug delivery systems. With a total of 2 patents, her work is paving the way for advancements in pharmaceutical formulations.

Latest Patents

Birte Nolting's latest patents include groundbreaking work on lipids and compositions thereof. One patent details lipids having specific formulas and their pharmaceutically acceptable salts. These lipids are integral to lipid nanoparticle (LNP) compositions that can deliver a capsid-free, non-viral DNA vector to targeted sites such as cells, tissues, and organs. Another patent further explores lipid nanoparticle compositions, emphasizing their potential in non-viral vector delivery systems.

Career Highlights

Birte Nolting is currently associated with Generation Bio Co., where she continues to innovate in the field of biotechnology. Her research focuses on developing lipid-based delivery systems that enhance the efficacy of therapeutic agents. Her contributions are vital in advancing the understanding and application of lipid nanoparticles in medicine.

Collaborations

Birte collaborates with notable colleagues, including Matthew G Stanton and Andrew Milstead. These partnerships foster a dynamic research environment that encourages the exchange of ideas and expertise, further enhancing the impact of their work.

Conclusion

Birte Nolting is a key figure in the development of lipid nanoparticle technology, with her patents reflecting her innovative spirit and dedication to improving drug delivery systems. Her work at Generation Bio Co. and collaborations with esteemed colleagues underscore her commitment to advancing the field of biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…